Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, CO
Phase II, double blind, efficacy and safety study of Enzalutamide vs. Bicalutamide in men with prostate cancer who have failed primary androgen deprivation therapy.
This study compares the effect of treatment with enzalutamide (formerly known as MDV3100) to the effect of treatment with bicalutamide in prostate cancer patients whose cancer has progressed while receiving hormone therapy.
Patient Inclusion Criteria:
Men who are currently receiving hormonal treatment and are still progressing
Patient Exclusion Criteria:
Current treatment with bicalutamide and history of seizures
The Urology Center of Colorado
2777 Mile High Stadium Cir
Denver, CO 80211
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these